Detalles de la búsqueda
1.
ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults.
Eur Respir J
; 63(3)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485149
2.
An open label trial of nemiralisib, an inhaled PI3 kinase delta inhibitor for the treatment of Activated PI3 kinase Delta Syndrome.
Pulm Pharmacol Ther
; 79: 102201, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841351
3.
Influenza-associated mortality in hospital care: a retrospective cohort study of risk factors and impact of oseltamivir in an English teaching hospital, 2016 to 2017.
Euro Surveill
; 24(44)2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690364
4.
Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A.
BMC Infect Dis
; 14: 660, 2014 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25466778
5.
Respiratory infectious burden in a cohort of antibody deficiency patients treated with immunoglobulin replacement therapy: The impact of lung pathology and gastroesophageal reflux disease.
J Allergy Clin Immunol Glob
; 2(4): 100133, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37781665
6.
Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons.
J Infect
; 86(3): 256-308, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36646142
7.
Introducing biomarkers for invasive fungal disease in haemato-oncology patients: a single-centre experience.
J Med Microbiol
; 71(7)2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819894
8.
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Nat Med
; 10(11): 1240-4, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15502839
9.
Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice.
J Immunol
; 181(7): 4955-64, 2008 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18802099
10.
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Am J Respir Crit Care Med
; 179(8): 724-33, 2009 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19151191
11.
Food for Thought: Dietary Intervention in a Rare Cause of Severe Ventilatory Failure.
Eur J Case Rep Intern Med
; 7(5): 001523, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32399441
12.
Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
Infect Immun
; 77(2): 622-31, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19064635
13.
Interstitial lung disease in systemic sclerosis: a simple staging system.
Am J Respir Crit Care Med
; 177(11): 1248-54, 2008 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18369202
14.
A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment.
J Med Microbiol
; 68(12): 1766-1770, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31746725
15.
Late respiratory effects of cancer treatment.
Curr Opin Support Palliat Care
; 11(3): 197-204, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28763349
16.
British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders.
J Allergy Clin Immunol Pract
; 5(4): 938-945, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28351785
17.
Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
Tuberculosis (Edinb)
; 85(1-2): 47-52, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15687027
18.
Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Vaccine
; 30(38): 5616-24, 2012 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22789508
19.
Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
PLoS One
; 6(8): e23463, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21887254
20.
A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults.
BMJ Open
; 1(2): e000223, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22102640